Profile data is unavailable for this security.
About the company
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The Company distributes its products both in the domestic market and to overseas markets.
- Revenue in HKD (TTM)285.25bn
- Net income in HKD4.09bn
- Incorporated1994
- Employees48.16k
- LocationShanghai Pharmaceuticals Holding Co LtdShanghai Pharmaceutical MansionNo.200 Taicang RoadSHANGHAI 200020ChinaCHN
- Phone+86 2 163730908
- Fax+86 2 163289333
- Websitehttps://www.sphchina.com/index/
More ▼
10.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Jul 2024 | 32.73m | 3.56% |
| BlackRock Fund Advisorsas of 04 Jun 2024 | 16.52m | 1.80% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 11.34m | 1.23% |
| BlackRock Advisors (UK) Ltd.as of 04 Jun 2024 | 9.53m | 1.04% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 5.73m | 0.62% |
| Swedbank Robur Fonder ABas of 28 Jun 2024 | 5.53m | 0.60% |
| Amundi Asset Management SA (Investment Management)as of 17 Jul 2024 | 5.08m | 0.55% |
| Brandes Investment Partners LPas of 18 Jul 2024 | 4.94m | 0.54% |
| Apo Asset Management GmbHas of 28 Mar 2024 | 4.64m | 0.50% |
| S-Bank Fund Management Ltd.as of 31 Dec 2023 | 4.32m | 0.47% |
More ▼
Data from 31 Mar 2024 - 17 Jul 2024Source: FactSet Research Systems Inc.
